This is an interesting article on a new network 'LaunchR', which will bring together WA and International rare disease experts. With an aim to develop precision medicines for rare diseases. Though PYC is not mentioned, LaunchR could very well play an important part in PYC's future drug development. A cut from the article reads "The scientific and medical expertise from the Centre for Molecular Medicine and Innovative Therapeutics (CMMIT) will be utilised to rapidly design, validate and manufacture ASOs in collaboration with other groups". https://www.perroninstitute.org/rare-disease-network-launched-to-help-solve-the-health-systems-hardest-cases/
PYC Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)